By Tony Fong
NEW YORK (GenomeWeb News) – Molecular diagnostics firm T2 Biosystems is set to begin a clinical trial for its first assay targeting Candida fungal infections as it prepares to seek regulatory approval in the US next year.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.
The New York Times editorial board weighs in on scientific research misconduct.
The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.
The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.